After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...
With investors appearing comparatively less rattled by recent uncertainty and market volatility, rising expectations of Fed rate cuts in 2026 and the prospect of a more accommodative regulatory ...
A surge in stablecoin adoption drives Bernstein’s bullish outlook.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results